V. Poulaki

发表

Inhibition of Hsp90 attenuates inflammation in endotoxin‐induced uveitis

Joan W. Miller, E. Gragoudas, N. Mitsiades, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.

I. Stamenkovic, N. Mitsiades, V. Poulaki, 2000, Cancer research.

A central role for inflammation in the pathogenesis of diabetic retinopathy

Ulrich Schraermeyer, Bernd Kirchhof, Sascha Fauser, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

N. Mitsiades, C. Mitsiades, A. Ashkenazi, 2002, The American journal of pathology.

Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression.

D. Leroith, T. Wood, V. Poulaki, 1998, Cancer research.

Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.

Joan W. Miller, E. Gragoudas, N. Mitsiades, 2009, Investigative ophthalmology & visual science.

Role of 4 Integrin ( CD 49 d ) in the Pathogenesis of Diabetic Retinopathy

Joan W. Miller, E. Gragoudas, N. Mitsiades, 2009 .

TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations

A. Joussen, V. Poulaki, T. Krohne, 2009, Molecular vision.

Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo.

B. Kirchhof, A. Joussen, V. Poulaki, 2003, Investigative ophthalmology & visual science.

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.

K. Anderson, T. Libermann, N. Munshi, 2003, Blood.

Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity

A. Joussen, V. Poulaki, T. Krohne, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines.

N. Mitsiades, C. Mitsiades, V. Poulaki, 2003, The Journal of clinical endocrinology and metabolism.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

Joan W. Miller, N. Mitsiades, C. Mitsiades, 2005, Investigative ophthalmology & visual science.

VEGF-dependent conjunctivalization of the corneal surface.

N. Mitsiades, B. Kirchhof, G. Yancopoulos, 2003, Investigative ophthalmology & visual science.

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

G. Yancopoulos, S. Wiegand, A. Joussen, 2002, The Journal of clinical investigation.

Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors.

N. Mitsiades, V. Poulaki, M. Tsokos, 1999, Journal of the National Cancer Institute.

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.

N. Mitsiades, C. Mitsiades, S. Treon, 2002, Blood.

ligand-induced apoptosis in human multiple myeloma cells Intracellular regulation of tumor necrosis factor-related apoptosis-inducing

N. Mitsiades, C. Mitsiades, S. Treon, 2002 .

Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.

N. Mitsiades, C. Mitsiades, V. Poulaki, 2001, Cancer research.

Animal Model Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium

R. D'Amato, A. Joussen, A. Adamis, 2001 .

Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug

N. Mitsiades, C. Mitsiades, V. Poulaki, 2001, Expert opinion on investigational drugs.

Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.

N. Mitsiades, V. Poulaki, M. Tsokos, 1998, The American journal of pathology.

Translational Protein Kinase C Inhibitors Sensitize GNAQ Mutant Uveal Melanoma Cells to Ionizing Radiation

Sean M. Hartig, M. Hamilton, S. McGuire, 2014 .

The role of Fas and FasL as mediators of anticancer chemotherapy.

N. Mitsiades, C. Mitsiades, V. Poulaki, 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone.

G. Chrousos, N. Mitsiades, V. Poulaki, 2001, Experimental eye research.

Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.

G. Chrousos, N. Mitsiades, V. Poulaki, 2000, Thyroid : official journal of the American Thyroid Association.

Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases

G. Chrousos, N. Mitsiades, C. Mitsiades, 2001, Trends in Endocrinology & Metabolism.

The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.

N. Mitsiades, C. Mitsiades, V. Poulaki, 2003, The Journal of endocrinology.

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

T. Libermann, Marie G. Joseph, N. Mitsiades, 2004, Cancer cell.

Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.

N. Mitsiades, C. Mitsiades, A. Joussen, 2004, The American journal of pathology.

Inhibition of inflammatory corneal angiogenesis by TNP-470.

B. Kirchhof, W. Beecken, A. Joussen, 2001, Investigative ophthalmology & visual science.

Retinectomy for treatment of intractable glaucoma: long term results

K. Bartz-Schmidt, P. Walter, B. Kirchhof, 2003, The British journal of ophthalmology.

Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.

N. Mitsiades, B. Kirchhof, F. Kruse, 2004, The American journal of pathology.

Rapid ocular angiogenic control via naked DNA delivery to cornea.

R. D'Amato, H. V. von Recum, A. Joussen, 2001, Investigative ophthalmology & visual science.

Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

I. Stamenkovic, N. Mitsiades, W. Yu, 2001, Cancer research.

Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1998, The Journal of clinical endocrinology and metabolism.

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications

D. McMillin, N. Mitsiades, C. Mitsiades, 2007, Molecular Cancer Therapeutics.

Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.

N. Mitsiades, V. Poulaki, S. A. Chew, 2011, Investigative ophthalmology & visual science.

Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.

N. Mitsiades, V. Poulaki, M. Tsokos, 2001, Cancer research.

Protein and bcl-2 Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Fas-mediated Apoptosis in Neuroblastoma Requires

N. Mitsiades, V. Poulaki, M. Tsokos, 2001 .

Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

Masaharu Akiyama, P. Richardson, N. Mitsiades, 2002, Oncogene.

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.

Marie Joseph, Masaharu Akiyama, T. Libermann, 2004, Proceedings of the National Academy of Sciences of the United States of America.

therapeutic applications B blockade in multiple myeloma: κ - Biologic sequelae of nuclear factor

N. Munshi, N. Mitsiades, C. Mitsiades, 2013 .

Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

N. Mitsiades, B. Kirchhof, C. Mitsiades, 2002, The American journal of pathology.

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

N. Munshi, P. Richardson, N. Mitsiades, 2002, Blood.

Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.

D. McMillin, Jake E. Delmore, N. Mitsiades, 2007, The Journal of clinical endocrinology and metabolism.

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

T. Libermann, N. Munshi, Marie G. Joseph, 2002, Proceedings of the National Academy of Sciences of the United States of America.

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.

Joseph Negri, Joan W. Miller, D. McMillin, 2007, Investigative ophthalmology & visual science.

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

D. McMillin, N. Mitsiades, C. Mitsiades, 2006, The Journal of clinical endocrinology and metabolism.

Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.

R. D'Amato, A. Joussen, A. Adamis, 2001, The American journal of pathology.

Retinal Vascular Permeability in Health and Disease

V. Poulaki, 2010 .

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

N. Munshi, P. Richardson, N. Mitsiades, 2002, Blood.

Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation.

Sean M. Hartig, S. McGuire, N. Mitsiades, 2014, Investigative ophthalmology & visual science.

Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation

D. McMillin, N. Mitsiades, C. Mitsiades, 2006, Clinical Cancer Research.

Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1999, The Journal of clinical endocrinology and metabolism.

Antimyeloma activity of heat shock protein-90 inhibition.

T. Libermann, G. Morgan, N. Munshi, 2005, Blood.

Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization

B. Kirchhof, S. Fauser, M. Paulsson, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid Carcinomas

N. Mitsiades, C. Mitsiades, V. Poulaki, 2003 .

The FASEB Journal express article 10.1096/fj.02-0157fje. Published online November 15, 2002. Suppression of Fas-FasL-induced endothelial cell apoptosis

Bernd Kirchhof, N. Mitsiades, B. Kirchhof, 2022 .

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.

Bernd Kirchhof, John Rudge, N. Mitsiades, 2002, The American journal of pathology.

Molecular sequelae of histone deacetylase inhibition in human malignant B cells.

N. Munshi, P. Richardson, P. Marks, 2003, Blood.

Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression

Bernd Kirchhof, N. Mitsiades, B. Kirchhof, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Suppression of diabetic retinopathy with angiopoietin-1.

S. Bursell, G. Yancopoulos, A. Tsujikawa, 2002, The American journal of pathology.

malignant B cells Molecular sequelae of histone deacetylase inhibition in human

N. Munshi, P. Richardson, P. Marks, 2013 .

Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.

Joan W. Miller, P. Marks, N. Mitsiades, 2009, Investigative ophthalmology & visual science.

Novel Histone Deacetylase Inhibitors in the Treatment of Thyroid Cancer

P. Marks, N. Mitsiades, C. Mitsiades, 2005, Clinical Cancer Research.

Avicins: A Novel Class of Anti-Myeloma Agents.

N. Munshi, N. Mitsiades, C. Mitsiades, 2004 .

VLA‐4 blockade suppresses endotoxin‐induced uveitis: in vivo evidence for functional integrin up‐regulation

T. Nakazawa, E. Gragoudas, A. Hafezi-Moghadam, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

N. Mitsiades, C. Mitsiades, G. Voutsinas, 2006, The Journal of clinical endocrinology and metabolism.

BMS-275291. Bristol-Myers Squibb.

V. Poulaki, 2002, Current opinion in investigational drugs.

In vivo retinal gene expression in early diabetes.

K. Camphausen, B. Kirchhof, W. Beecken, 2001, Investigative ophthalmology & visual science.

Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias

N. Mitsiades, C. Mitsiades, S. Treon, 2001, Expert opinion on investigational drugs.

The mTOR Inhibitor RAD001 (everolimus) Is Active Against Multiple Myeloma Cells In Vitro and in Vivo.

N. Munshi, H. Lane, P. Richardson, 2004 .

Non-steroid Alanti-inflammatory Drugs Prevent Early Diabetic Retinopathy: Aspirinand COX-2 Inhibition Prevent Blood-retinal Barrier Breakdown and Leukocyte Adhesion Via TNF-asuppression

B. Kirchhof, A. Joussen, A. Adamis, 2002 .

Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.

Joan W. Miller, P. Marks, N. Mitsiades, 2009, Investigative ophthalmology & visual science.

p53 expression and regulation by NMDA receptors in the developing rat brain

V. Poulaki, V. Poulaki, F. Stylianopoulou, 1999, Journal of neuroscience research.